Lye D C B, Hughes A, O'Brien D, Athan E
Department of Infectious Diseases, Level 7, Geelong Hospital, Ryrie Street, PO Box 281, Geelong, 3220, Victoria, Australia.
Eur J Clin Microbiol Infect Dis. 2005 Nov;24(11):753-5. doi: 10.1007/s10096-005-0038-2.
Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery. Initial treatment with intravenous amphotericin B resulted in acute renal impairment. Despite 8 days of intravenous fluconazole therapy, he remained fungemic. Caspofungin was added to the treatment regimen with subsequent sterilisation of blood culture. The patient was treated for 34 days with caspofungin and 41 days with fluconazole. He continued oral fluconazole after hospital discharge and remained well at follow-up 11 months later. The role of fluconazole and caspofungin in the treatment of Candida endocarditis is discussed.
本文报告了一例72岁男性患者,该患者被诊断为光滑念珠菌人工二尖瓣心内膜炎,在拒绝手术且被判定不宜进行手术后,接受氟康唑联合卡泊芬净治疗并获成功。最初静脉注射两性霉素B治疗导致急性肾功能损害。尽管静脉注射氟康唑治疗8天,但他仍有真菌血症。在治疗方案中加用卡泊芬净后血培养随后转阴。患者接受卡泊芬净治疗34天,氟康唑治疗41天。出院后他继续口服氟康唑,11个月后随访情况良好。文中讨论了氟康唑和卡泊芬净在念珠菌性心内膜炎治疗中的作用。